Delsia, 3 mg+0.03 mg 21 pcs

Contraception.

Active ingredient

Drospirenone, Ethinylestradiol

How to take, the dosage

Tablets should be taken orally in the order listed on the package at about the same time each day, with a small amount of water. You should take 1 tablet continuously for 21 days. The pills from the next package start after a 7-day break, during which menstrual bleeding (bleeding “cancellation”) is usually observed. It usually begins on the 2nd or 3rd day after taking the last pill and may not end until the pills from the new package start.

Interaction

Interaction of OCs with other medications may result in “breakthrough” bleeding and/or decreased contraceptive reliability. Women taking these drugs should temporarily use barrier methods of contraception in addition to Delsia or choose another method of contraception.

Contraindications

– Thrombosis (venous and arterial) currently or in the anamnesis (including deep vein thrombosis, pulmonary embolism, myocardial infarction, cerebrovascular disorders);
– conditions that preceded thrombosis (including transient ischemic attacks, atrial fibrillation, angina pectoris). Transient ischemic attacks, atrial fibrillation, angina pectoris) at present or in anamnesis:
– identified predisposition to venous or arterial thrombosis, including resistance to activated protein C, antithrombin III deficiency, protein C deficiency, protein S deficiency, hyperhomocysteinemia. Antibodies to phospholipids (antibodies to cardiolipin, lupus anticoagulant);
– migraine with focal neurological symptoms at present or in anamnesis;
– diabetes with diabetic angiopathy;
– multiple or expressed risk factors of venous or arterial thrombosis (including Complicated heart valve defects, atrial fibrillation, diseases of the brain vessels or coronary arteries; uncontrolled arterial hypertension, prolonged immobilization, massive surgery, surgical interventions on the lower extremities, in the pelvis, neurosurgical operations, major injuries, smoking over 35 years, obesity with a body mass index more than 30 kg/m2; severe dislipoproteinemia; Air flight longer than 4 hours);
– pancreatitis with significant hypertriglyceridemia at present or in anamnesis;
– hepatic insufficiency and severe liver disease (before normalization of liver function tests and within 3 months after the return of these values to normal);
– hepatic tumors (benign or malignant) at present or in the anamnesis;
– severe renal insufficiency and/or acute renal failure:
– identified hormone-dependent malignancies (including.ч. Genital organs or mammary glands) or suspicion of them:
– bleeding from the vagina of unclear genesis;
– pregnancy or suspicion of it;
– period of breastfeeding;
– Hypersensitivity to the components of the drug;